SCHEMBL5878561

SCHEMBL5878561

NCCCC1(CCCN)CCCCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
CYP1A2 P05177 1/20 0.38
TSHR P16473 1/20 0.38
BLM P54132 1/20 0.38
CACNA2D1 P54289 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GRIN2D O15399 2/20 0.36
GRIN3B O60391 2/20 0.36
GRIN1 Q05586 2/20 0.36
GRIN2A Q12879 2/20 0.36
GRIN2B Q13224 2/20 0.36
GRIN2C Q14957 2/20 0.36
GRIN3A Q8TCU5 2/20 0.36
CPB2 Q96IY4 5/20 0.34
HTR1A P08908 1/20 0.33
HTR1B P28222 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5073354 0.90 USP2 (0.45) USP2ALDH1A1LMNACYP1A2TSHR
SCHEMBL8966757 0.86 USP2 (0.41) USP2ALDH1A1LMNACYP1A2TSHR
SCHEMBL158419 0.82 USP2 (0.41) USP2ALDH1A1LMNACYP1A2TSHR
SCHEMBL9209118 0.82 GRIN2D (0.32) USP2ALDH1A1LMNACYP1A2TSHR
SCHEMBL9206671 0.80 DNM1 (0.52) ALDH1A1TSHRCPB2
SCHEMBL9213432 0.77 DNM1 (0.48) ALDH1A1LMNATSHRBLMCPB2
SCHEMBL3193842 0.76 GRIN2D (0.34) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL21104961 0.74 GRIN2D (0.33) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL1670149 0.74 GRIN2D (0.33) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL25392869 0.72 CETP (0.33) LMNACYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12180136-B2 Organic amine collection method ASAHI KASEL KABUSHIKI KAISHA (JP) 2024-12-31 US claimed
CN-118307416-A Method for synthesizing special amine compound by one-step method 中海油天津化工研究设计院有限公司 2024-07-09 CN claimed
US-20230139979-A1 ORGANIC AMINE COLLECTION METHOD ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-05-04 US claimed
EP-3872062-B1 ORGANIC AMINE COLLECTION METHOD ASAHI CHEMICAL IND (JP) 2022-09-07 EP claimed
CN-111183131-B Method for recovering organic amine 旭化成株式会社 2022-06-28 CN claimed
CN-119775147-B Method for preparing N, N-diaminopropyl cyclohexylamine based on cyclohexylamine 山东理工大学 2025-06-24 CN disclosed
CN-119775147-A Method for preparing N, N-diaminopropyl cyclohexylamine based on cyclohexylamine 山东理工大学 2025-04-08 CN disclosed
US-12180136-B2 Organic amine collection method ASAHI KASEL KABUSHIKI KAISHA (JP) 2024-12-31 US disclosed
CN-118307416-A Method for synthesizing special amine compound by one-step method 中海油天津化工研究设计院有限公司 2024-07-09 CN disclosed
CN-118307416-A Method for synthesizing special amine compound by one-step method 中海油天津化工研究设计院有限公司 2024-07-09 CN disclosed
US-20230139979-A1 ORGANIC AMINE COLLECTION METHOD ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-05-04 US disclosed
US-11578030-B2 Organic amine collection method ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-02-14 US disclosed
EP-3733644-B1 ORGANIC AMINE COLLECTION METHOD ASAHI CHEMICAL IND (JP) 2022-09-07 EP disclosed
CN-111183131-B Method for recovering organic amine 旭化成株式会社 2022-06-28 CN disclosed
US-20210155573-A1 ORGANIC AMINE COLLECTION METHOD ASAHI KASEI KABUSHIKI KAISHA (JP) 2021-05-27 US disclosed
EP-3733644-A1 ORGANIC AMINE COLLECTION METHOD Asahi Kasei Kabushiki Kaisha (JP) 2020-11-04 EP disclosed
CN-111183131-A Method for recovering organic amine 旭化成株式会社 2020-05-19 CN disclosed
US-7060706-B1 Quinazolinones 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2006-06-13 US disclosed
EP-1216233-A1 QUINAZOLINONES MERCK PATENT GmbH (DE) 2002-06-26 EP disclosed
WO-2001023364-A1 QUINAZOLINONES MERCK PATENT GMBH (DE) 2001-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230139979-A1 ORGANIC AMINE COLLECTION METHOD H1-0, F12, C1S USP2 3553/4885ALDH1A1 1007/4885LMNA 3501/4885
US-11578030-B2 Organic amine collection method H1-0, C1S, NGLY1 USP2 3398/4885ALDH1A1 1315/4885LMNA 3156/4885
US-12180136-B2 Organic amine collection method H1-0, F12, C1S USP2 3553/4885ALDH1A1 1007/4885LMNA 3501/4885
US-20210155573-A1 ORGANIC AMINE COLLECTION METHOD H1-0, C1S, NGLY1 USP2 3398/4885ALDH1A1 1315/4885LMNA 3156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.